A nonprofit organization awarded UCLA and four other universities a $13.9 million grant to study how elderly people with chronic depression respond to treatment. The Patient-Centered Outcomes Research Institute selected UCLA for the depression research study because UCLA researchers published a paper on the potential of methylphenidate to improve antidepressant response to citalopram. Read more...
Photo: Helen Lavretsky, a geriatric psychiatrist and lead researcher of the Optimizing Outcomes of Treatment-Resistant Depression in Older Adults study, said OPTIMUM will help physicians better recommend more effective depression treatments. (Courtesy of Helen Lavretsky)





